Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaAdebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study
- Where
- Harbin
- Életkor
- 18 év to 99 év
- People
- 47
- Run by
- The Third Affiliated Hospital of Harbin Medical University
See details and how to joinNCT07398560 - 2. fázisTaking peopleComparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 116
- Run by
- Fudan University
See details and how to joinNCT07398937 - No phaseTaking peopleNoninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 240
- Run by
- Baohui Han
See details and how to joinNCT07399210 - 2. fázisTaking peopleMulticenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
- Where
- Sichuan
- Életkor
- 18 év to 75 év
- People
- 202
- Run by
- Sichuan University
See details and how to joinNCT06610734 - No phaseTaking peopleA Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Foshan, Fuzhou, Guangzhou, Harbin, Hefei, Kunming, Meizhou, Nanchang, Nanjing, Nanning, Qingdao, Shenyang, Shenzhen, Taiyuan, Tianjin, Wuhan, Xiamen, Yangzhou, Zhenzhou
- Életkor
- 18 év and over
- People
- 800
- Run by
- Alpha Biopharma (Jiangsu) Co., Ltd.
See details and how to joinNCT07143045 - No phaseTaking peopleFunctional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study
- Where
- Chongqing
- Életkor
- 18 év to 85 év
- People
- 100
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07339644 - No phaseNot yet taking people in KínaNon-intubated Versus Intubated Anesthesia for Thoracoscopic Sublobar Resection
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 1600
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07395375 - 1. fázisTaking peopleA Study of SH009 Injection in Patients With Advanced Solid Tumors.
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 150
- Run by
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
See details and how to joinNCT07390838 - 2. fázisNot yet taking people in KínaAdebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 76
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07381543 - 3. fázisNot yet taking people in KínaPhase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT07383116 - 1. fázisTaking peopleA Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 328
- Run by
- HC Biopharma Inc.
See details and how to joinNCT07381829 - 2. fázisTaking peopleIntrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
- Where
- Huizhou
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Guangzhou Medical University
See details and how to joinNCT06296745 - No phaseCsak meghívásosRetrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 380
- Run by
- Ming Yang
See details and how to joinNCT07373951 - No phaseTaking peopleIruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
- Where
- Shenzhen
- Életkor
- 18 év and over
- People
- 20
- Run by
- Peking University Shenzhen Hospital
See details and how to joinNCT07374614 - No phaseNot yet taking people in KínaA Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study
- Where
- Changchun, Kunming, Shanghai, Shenyang, Shijiazhuang, Zhengzhou
- Életkor
- 40 év to 74 év
- People
- 14 300
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07375979 - 1. fázisTaking peopleA Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 194
- Run by
- Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT07376707 - 2. fázisCsak meghívásosthe Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 41
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06370416 - 4. fázisTaking peopleEffects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
- Where
- Wuhan
- Életkor
- 40 év to 80 év
- People
- 1058
- Run by
- Tongji Hospital
See details and how to joinNCT07028593 - 1/2. fázisTaking peopleAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- Where
- Beijing, Hangzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 266
- Run by
- Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07371663 - 2. fázisTaking peopleA Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
- Where
- Shenyang
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- China Medical University, China
See details and how to joinNCT07373964 - No phaseTaking peopleA Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery
- Where
- Beijing
- Életkor
- 65 év and over
- People
- 174
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06674252 - No phaseTaking peopleResearch on Early Screening and Diagnosis of Pulmonary Nodules Based on Novel Non-invasive Technologies.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 1800
- Run by
- Chen KeZhong
See details and how to joinNCT07370077 - No phaseNot yet taking people in Kína18F-FAPI PET in Lung Cancer
- Where
- Hangzhou
- Életkor
- 20 év to 85 év
- People
- 120
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07370805 - 2. fázisNot yet taking people in KínaFurmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07365410 - 1. fázisTaking peopleFirst in Human Study of SIM0610 in Solid Tumors
- Where
- Chongqing, Harbin, Jinan, Shanghai, Shenyang
- Életkor
- 18 év and over
- People
- 260
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211